cd19-targeted car t-cell therapy in managing dlbcl
Published 4 years ago • 94 plays • Length 8:33Download video MP4
Download video MP3
Similar videos
-
45:46
cd19 targeted car t-cell therapy in lbcl
-
5:55
car t-cell therapy in dlbcl
-
5:12
car t: cd19-targeted therapy in r/r dlbcl
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
29:00
dlbcl in 2023: top docs discuss the latest in diffuse large b-cell lymphoma | treatments & research
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
29:38
dlbcl treatment approaches: what you need to know
-
3:16
cd19-targeted mabs in relapsed/refractory dlbcl
-
3:01
candidates for car t-cell therapy in dlbcl
-
2:23
outcomes in progressive large b-cell lymphomas following cd19-specific car t cells
-
2:52
anti-cd19 monoclonal antibody therapy in dlbcl
-
51:15
management of relapsed dlbcl in era of car t therapy
-
1:12
evaluating the role of car t-cell therapy in relapsed/refractory dlbcl
-
1:37
dr. wierda on using cd19-targeted car t cells in cll
-
1:38
car t-cell therapy appears promising in relapsed/refractory dlbcl
-
1:24
dr. park on using cd19-targeted car t cells as treatment for all
-
3:26
lymphodepletion for car t-cell therapies in dlbcl
-
4:46
treatment of r/r dlbcl: cd19-targeted monoclonal antibodies
-
2:36
cd19- and cd22-directed chimeric antigen receptor t-cell therapy in childhood b-cell all
-
1:51
analyzing real-world data for car t-cell therapy in patients with all and dlbcl
-
1:18
dr. maziarz on unanswered questions with car t-cell therapy in dlbcl
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells